Galapagos NV: business update: http://t.co/6w1jppWE
posted 4 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today issued an update on its filing plans and pre-commercialization activities for its lead product ocriplasmin. read more
Peira is one of the companies that participates in the Belgian Economic Mission to the US and puts two new developments, designed in Flanders-Belgium, on display at the Bio 2011 International Convention. The Bio Convention is one of the largest events for companies and research organisations active in life sciences/biotechnoloy. The Belgian booth will host more than 60 Belgian companies active in the field. The Flemish representation at the convention is organised by FlandersBio, the cluster organisation for the biotech sector in Flanders, and FIT. This year the Pavilion will be inaugurated by H.R.H. Prince Philippe on Tuesday 28 June 2011. read more
Applied Maths today announces that Bayer CropScience has decided to implement the BioNumerics platform globally for its plant breeding program. The choice for BioNumerics was incentivized by the software’s comprehensive databasing and analysis tools, enabling workers to deploy one uniform software platform for diverse projects and techniques. IT managers and bioinformaticians at Bayer CropScience greatly valued the flexible scripting possibilities using Python as an instrument to integrate the BioNumerics software with existing tools and realize automatic workflows for high-throughput data management. read more
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, announces that it has incorporated a wholly owned subsidiary in Delaware, USA. The subsidiary is called Cryo-Save USA, Inc. and will commercialize and further develop the Cryo-Lip® service in North America. Cryo-Lip® allows adults to store stem cells from fat tissue which is extracted whilst undergoing other surgical procedures. read more
HIV researchers at CDC and across the globe are keeping close watch on the rapid mutations of HIV and its threat of resistance to current and novel therapies. In order to track variant, atypical and drug resistant HIV strains, smart systems are required that can rapidly process information from multiple sources into clear and reportable summarizations. Critical understanding of mutations in HIV is needed to allow physicians and public health policy makers to make treatment decisions and to create preventive measures. read more
BD (Becton, Dickinson and Company) introduceert de BD Vacutainer® Rapid Serum Tube, een bloedafnamebuis die ontworpen is om de spoedeisende hulp ertoe in staat te stellen snel serum te analyseren voor diagnose. De BD Vacutainer® Rapid Serum Tube heeft een BD Hemogard™-veiligheidsdop die de veiligheid van gezondheidswerkers en de compatibiliteit met klinische analyse-instrumenten met preanalytische modules verbetert. read more
BD Diagnostics, een onderdeel van BD (Becton, Dickinson and Company), maakte vandaag bekend dat het productaanbod wordt uitgebreid met de BD InnovaTM Preanalytical Automated Microbiology Specimen Processor, die speciaal is ontworpen om de laboratoriumefficiëntie te verhogen en de moderne microbiologische laboratoria te automatiseren. read more
BD Diagnostics, een onderdeel van BD (Becton, Dickinson and Company), heeft vandaag de Europese lancering bekendgemaakt van het BD MAXTM Automated Molecular Diagnostic System en de BD MAX™ GBS Assay, de eerste in een breed scala van assays voor besmettelijke ziektes. Het BD MAX-systeem is een volledig geautomatiseerd werkstation voor het uitvoeren van individuele en batch testen. Het is bijzonder geschikt bij een variërende werkbelasting en biedt maximale efficiëntie en flexibiliteit. Dankzij dit systeem kunnen gebruikers hun eigen volledig geautomatiseerde assays ontwikkelen op een open architectuur. Het systeem werd gepresenteerd op het European Congress of Clinical Microbiology and Infectious Diseases. read more
TiGenix (NYSE EURONEXT: TIG) received a Pharmacotherapeutic Report, prepared by the Dutch College for Healthcare Insurance (“Nederlandse College voor Zorgverzekeringen” or “CVZ”) advising the Dutch Healthcare Authorities against the reimbursement of ChondroCelect under the policy rule of expensive medicinal products (“Beleidsregel Dure Geneesmiddelen”). read more
